Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-314468
Filing Date
2025-12-10
Accepted
2025-12-10 17:45:16
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12003
  Complete submission text file 0001193125-25-314468.txt   13431
Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MERUS N.V. VALELAAN 62 UTRECHT P7 3584 CM
Business Address
Shuman Harry (Reporting) CIK: 0001791115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37773 | Film No.: 251562923